Skip to main content
Vitrolife logo

Vitrolife — Investor Relations & Filings

Ticker · VITR ISIN · SE0011205202 LEI · 5493001WDZMONMSPPR49 ST Manufacturing
Open in API
Filings indexed 654 across all filing types
Latest filing 2025-02-21 Board/Management Inform…
Country SE Sweden
Listing ST VITR

About Vitrolife

https://www.vitrolife.com/

Vitrolife is a global company focused on reproductive health, providing medical devices and genetic testing services primarily to In Vitro Fertilization (IVF) clinics. The company develops, produces, and markets a comprehensive portfolio of products and solutions that support the entire assisted reproduction treatment journey, from oocyte retrieval and sperm preparation to fertilization, embryo culture, evaluation, transfer, and cryopreservation. With a strong emphasis on quality control, innovation, and clinical support, Vitrolife aims to improve treatment outcomes and operational efficiency for its partners. The company also offers educational resources and training for professionals through its Vitrolife Academy.

Recent filings

Filing Released Lang Actions
Vitrolife Group utser Ermanno Sironi till Chief Operating Officer
Board/Management Information Classification · 100% confidence The document announces the appointment of Ermanno Sironi as the new Chief Operating Officer (COO) for Vitrolife Group, detailing the responsibilities of the new role and providing quotes from the CEO. This is a direct announcement regarding a change in senior management personnel. This aligns perfectly with the definition for Board/Management Information (MANG). The document is short and specific, not a comprehensive report or a general regulatory filing.
2025-02-21 Swedish
The Vitrolife Group appoints Ermanno Sironi as Chief Operating Officer
Board/Management Information Classification · 100% confidence The document is a press release announcing a specific change in senior management: the appointment of Ermanno Sironi as Chief Operating Officer (COO). This directly aligns with the definition for Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-02-21 English
Earnings Release 2024
Earnings Release Classification · 98% confidence The document is titled "BOKSLUTSKOMMUNIKÉ / 2024" which translates to "Year-End Report Communication / 2024" or "Year-End Press Release / 2024". It contains detailed financial highlights for the Fourth Quarter (Q4 2024) and the Full Year (Helåret 2024), including revenue, gross margin, EBITDA, net income, and EPS comparisons to the previous year (2023). It also includes a CEO commentary summarizing the year's performance and strategic updates. This structure—a summary of period results, key figures in tables, and management commentary—is characteristic of an Earnings Release (ER) or a preliminary report preceding a full Annual Report (10-K). Since it focuses on the period results (Q4 and Full Year) and is presented as a 'kommuniké' (communication/release), it aligns best with the 'Earnings Release' (ER) definition, which covers initial announcements of periodical financial results (key highlights only). Although it is quite detailed, it is presented as a communication piece rather than the comprehensive, audited 10-K filing itself. The mention of proposed dividend (Utdelning) also supports this being a period-end results announcement. Q4 2024
2025-01-30 Swedish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FOURTH QUARTER AND FULL YEAR REPORT / 2024' for Vitrolife Group. It contains comprehensive financial statements, detailed performance analysis by region and business area, CEO commentary, and key financial figures for the period. It is a substantive financial report covering a period shorter than a full fiscal year (Q4) and the full year, fitting the definition of an Interim/Quarterly Report. Q4 2024
2025-01-30 English
Patrik Tolf steps down as CFO of the Vitrolife Group - Helena Wennerström appointed acting CFO
Board/Management Information Classification · 100% confidence The document is a press release announcing the resignation of the current CFO and the appointment of an acting CFO. This falls directly under the category of changes in senior management.
2024-12-03 English
Patrik Tolf slutar som CFO för Vitrolife Group - Helena Wennerström utsedd till tillförordnad CFO
Board/Management Information Classification · 100% confidence The document is an official announcement regarding the departure of the current CFO and the appointment of an interim CFO at Vitrolife Group. This falls directly under the category of management changes, which is defined as 'Announcement of changes in the company's board of directors or senior management'.
2024-12-03 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.